Navigation Links
German High Court Rules in Favor of AmniSure® as New European Guidelines Published
Date:3/4/2011

KARLSRUHE, Germany, March 4, 2011 /PRNewswire/ -- The High Court of Germany (Bundesgerichtshof) handed down a final ruling in favor of AmniSure® International, LLC in its dispute with the Finnish company Medix Biochemica. The court upheld the German Patent Court's ruling that the patent associated with Medix's ActimPROM test is null and void due to its lack of an inventive step. Medix is expected to pay AmniSure® an undisclosed amount to be determined by the courts.

"We are extremely pleased with the decision of the German High Court," said Dr. Michael Friedman, President and CEO of AmniSure® International. "The Court's decision coincided with the publication of the new peer-reviewed Guidelines of the European Association of Perinatal Medicine, which hailed the AmniSure® test as the 'most useful tool' and the 'most accurate bedside test' for diagnosing ruptured fetal membranes(1). The Court's decision closes a chapter for us by bringing a seven-year-long litigation, initiated by Medix, to its rightful conclusion. The publication of the European Guidelines, meanwhile, opens a new chapter for us by establishing the AmniSure® test as the new benchmark for diagnosing ruptured fetal membranes."

(1) The Journal of Maternal-Fetal and Neonatal Medicine, March 2011. ISSN 1476-7058

About AmniSure® International, LLCAmniSure® International, LLC (http://www.amnisure.com) is a medical device company that operates internationally with headquarters in Boston, MA. AmniSure® International pioneered a rapid diagnostic device, AmniSure® ROM Test, which solves a long-standing problem in obstetrics and is rapidly becoming a new global standard in maternal fetal medicine. Contact:info@amnisure.com  617-234-4441 Tel.This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE AmniSure International, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
2. Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010
3. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
4. Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor
5. Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer
6. Ziehm Imaging Provides Germanys Federal Armed Forces (Bundeswehr) With Mobile X-Ray Systems
7. WATCHMAN® Receives German Reimbursement Coverage
8. ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firms Growing Client Base in Germany
9. Otix Global, Inc. to Discontinue German Operations
10. German District Court Finds RENASYS™ GO NPWT System Non-infringing
11. Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):